HealthStats NSW
HealthStats NSW
HealthStats NSW

Respiratory diseases hospitalisations

Females, All LHDs
1610.5 (1598.3, 1622.8)Females, Far West
1852.2 (1644.2, 2077.9)Females, Western NSW
2235.5 (2160.6, 2312.2)Females, Murrumbidgee
2454.3 (2369.6, 2541.1)Females, Southern NSW
1558.7 (1485.8, 1634.1)Females, Mid North Coast
1609.8 (1537.7, 1684.2)Females, Northern NSW
1603.5 (1540.9, 1667.8)Females, Hunter New England
1647.5 (1612.1, 1683.4)Females, Central Coast
1759.8 (1699.4, 1821.7)Females, Northern Sydney
1368.5 (1335.9, 1401.7)Females, Nepean Blue Mountains
1812.4 (1753.4, 1872.8)Females, Western Sydney
1508.6 (1474.3, 1543.4)Females, Illawarra Shoalhaven
1562.2 (1510.3, 1615.3)Females, South Eastern Sydney
1257.7 (1225.9, 1290.1)Females, South Western Sydney
1775.9 (1739.8, 1812.5)Females, Sydney
1270.5 (1232, 1309.9)Males, All LHDs
1837.2 (1824, 1850.5)Males, Far West
2131.7 (1911.3, 2369.7)Males, Western NSW
2308.5 (2233.2, 2385.6)Males, Murrumbidgee
2665.3 (2578.3, 2754.3)Males, Southern NSW
1778.2 (1701.9, 1857)Males, Mid North Coast
1773.2 (1697.6, 1851.1)Males, Northern NSW
1778 (1712.3, 1845.4)Males, Hunter New England
1814.8 (1777.6, 1852.5)Males, Central Coast
1881.5 (1819.3, 1945.2)Males, Northern Sydney
1599.9 (1564, 1636.4)Males, Nepean Blue Mountains
1991.8 (1928.5, 2056.6)Males, Western Sydney
1718.9 (1681.4, 1757.1)Males, Illawarra Shoalhaven
1691.8 (1637.9, 1746.9)Males, South Eastern Sydney
1448.8 (1414, 1484.3)Males, South Western Sydney
1978.3 (1939.4, 2017.8)Males, Sydney
1679.3 (1633.5, 1726)
  • + Source

    NSW Admitted Patient Data Collection and ABS population estimates (SAPHaRI). Centre for Epidemiology and Evidence, NSW Ministry of Health.

  • + Notes

    The 'Remaining respiratory diseases' category include respiratory diseases, such as asbestosis, silicosis, pleural diseases, abscesses, pulmonary oedema and others.

    Only NSW residents are included. Rehabilitation episodes are excluded. Figures are based on where a person resides, rather than where they are treated. Hospital separations were classified using ICD-10-AM. Rates were age-adjusted using the Australian population as at 30 June 2001.

    Numbers for recent years include an estimate of the small number of hospitalisations of NSW residents in interstate public hospitals, data for which were unavailable at the time of production. Further details can be found in the Methods tab in the following HealthStats NSW indicator: http://www.healthstats.nsw.gov.au/Indicator/bod_hos_cat

    A recent policy change (PD2017_015) resulted in patients treated solely within the emergency department being excluded from this indicator report. Please note that a minority of patients being managed in short stay areas of emergency departments are still included. Further information is found in a paper in the HealthStatsPLUS Methods tab on this website.

    Data for some LHDs may not be included individually due to low numbers. All LHDs include Albury Local Government Area and those LHDs where numbers are low and records where the LHD was missing or not stated.  

    LL/UL 95%CI = lower and upper limits of the 95% confidence interval for the point estimate.

  • + Data Table
  • + Download
    • Add to My Report
    • Download the indicator content
    • Download the data
    • Download the associated information
    • Download the graph image
  • + Methods
  • + Codes
    • Codes: Selected respiratory diseases

      The International Statistical Classification of Diseases and Related Health Problems

      National Centre for Classification in Health, Australia; AM - Australian Modification
      DescriptionICD-10 & ICD-10-AMComments
      Respiratory diseases: Total J00-J99

      All records are included except those involving rehabilitation, NSW residents only, all ages.

      Episodes that are entirely within an emergency department are excluded.

      Influenza and pneumonia J09-J18

      All other acute upper (J00-J06) and lower (J20-J22) respiratory infections

      J00-J06 or J20-J22
      Asthma J45, J46
      Chronic obstructive pulmonary disease J40-J44
      Lung dust disease J60-J67
      Remaining respiratory diseases J07, J08, J19, J23-J39, J47-J59, J68-J99
      Cancer: lung. This type is not included in the Total of respiratory diseases. C33-C34

      Where small numbers do not allow reporting of hospitalisations for lung dust disease, these are included in remaining respiratory diseases

  • + Related Indicators
  • + Associated Information
    • Key points: Respiratory disease

      • In 2018 in NSW, 10.5% of adults aged 16 years and over (9.0% of men and 12.9% of women) had asthma currently, as estimated from the 2018 NSW Adult Population Health Survey (self-reported using a Computer Assisted Telephone Interview or CATI). In 2016-2017, 14.5% of boys and 11.1% of girls aged 2-15 years were reported to currently have asthma, with 21.7% of boys and 17.2% of girls reported as ever having asthma, as estimated from the NSW Population Health Survey (self-reported using a Computer Assisted Telephone Interview or CATI). Asthma was responsible for 165 deaths in 2017 and 10,880 hospitalisations in 2017-18.

      • Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, was responsible for 2,564 deaths in 2017 in NSW (91% or 2,332 in those aged 65 years and over) and more than 22,720 hospitalisations in 2017-18. 

      • Asbestosis is a chronic lung dust disease that is associated with occupational exposure to asbestos. Total hospitalisations due to asbestos in NSW have steadily decreased in recent years. 

    • Introduction: Respiratory disease

      Respiratory diseases

      Respiratory diseases include acute diseases such as influenza and pneumonia, and chronic respiratory diseases (specifically asthma, chronic obstructive pulmonary disease, asbestosis, and respiratory tuberculosis), where preventive measures and better management of conditions can reduce the burden of disease and reduce associated healthcare costs.

      Chronic respiratory diseases were responsible for 7.5% of the total burden of disease and injury in Australia in 2015, with chronic obstructive pulmonary disease and asthma accounting for 51.4% and 33.8% of this burden, respectively (AIHW 2019).

      Influenza and pneumonia

      Influenza and pneumonia are acute respiratory diseases that can be very severe and, in persons at high risk, can lead to death. Influenza and pneumonia cause around 2.5% of all deaths and around 0.9% of hospital separations and are an important cause of hospitalisations in the very young, and of death and hospitalisations among older age groups.

      Asthma

      Asthma is a significant public health problem in Australia and it is estimated that Australian prevalence rates are among the highest in the world. Fortunately, recent studies in children show no further increase in prevalence. In Australia in 2015, asthma was estimated to account for 2.5% of the disease burden (AIHW 2019).

      Chronic obstructive pulmonary disease

      Chronic bronchitis and emphysema are the two main conditions comprising chronic obstructive pulmonary disease (COPD). In Australia in 2015, COPD was estimated to account for 3.9% of the disease burden (AIHW 2019).

      Tuberculosis

      Tuberculosis (TB) is caused by the bacterial organism Mycobacterium tuberculosis. Despite the increasing burden from respiratory tuberculosis globally, it is not a major public health problem in NSW. In fact the mortality and morbidity from all types of tuberculosis in NSW is one of the lowest in the world.

      Lung cancer

      Lung cancer is usually excluded from analyses of respiratory diseases as it is classified with cancers in the International Classification of Diseases (the coding system used for health data in NSW). It has been included with respiratory diseases here to provide a more appropriate measure of the burden of respiratory disease from a clinical and health services planning perspective.

      Risk factors

      Cigarette smoking is the main risk factor for both COPD and lung cancer and the current incidence rates of these conditions reflect smoking rates 20 years and more in the past. Lung cancer is one of the leading causes of death in Australia.

      References

      Australian Institute of Health and Welfare 2019. Australian Burden of Disease Study: Impact and causes of illness and death in Australia 2015. Australian Burden of Disease Study series no. 19. BOD 22. Canberra: AIHW. Available at: https://www.aihw.gov.au/reports/burden-of-disease/burden-disease-study-illness-death-2015/contents/table-of-contents

    • Interventions: Respiratory diseases

      Asthma

      Written asthma management plans are recommended as part of the national guidelines for the management of asthma: Australian Asthma Handbook (NACA 2015). They enable people with asthma to recognise a deterioration in their condition and initiate appropriate treatment, thereby reducing the severity of acute episodes.

      The Australian Asthma Handbook promotes preventive care activities, proper inhaler technique and adherence and stepped medical management where the use of medicines can be increased or decreased depending on circumstances and the therapy combinations.

      Tuberculosis

      Australia is fortunate in having one of the lowest rates of TB in the world. This has been primarily achieved as a result of a continued commitment to provide specialised health services dedicated to the prevention and control of TB in each of the states and territories. The National TB Advisory Committee’s Strategic Plan for the Control of Tuberculosis, 2011-2015 sets out the goals and objectives of TB control in Australia.

      Despite Australia’s success in reducing TB, there is no room for complacency. Global connectivity through air travel and migration means that TB will remain a public health concern in Australia until worldwide control of TB is achieved. The NSW TB Program is the provider of specialised services for the prevention and control of TB in NSW and plays a vital role in maintaining Australia’s success in reducing the burden of TB.

      Influenza and pneumonia

      Influenza and pneumococcal disease are covered by the National Immunisation Programs in NSW.

      Influenza has been a notifiable disease by all laboratories under the Public Health Act in NSW since 2001. Surveillance is enhanced in winter months when the NSW Ministry of Health collects and reports weekly on influenza-like illness presentations to Emergency Departments, through the Public Health Rapid, Emergency, Disease and Syndromic Surveillance System (PHREDSS), and laboratory-confirmed diagnoses of influenza virus infections.

      Emergency Departments in NSW are prepared for influenza epidemics with peak visit plans and similar measures in winter months.

      References

      National Asthma Council Australia. Australian Asthma Handbook. NACA, 2015. Available at: https://www.nationalasthma.org.au/health-professionals/australian-asthma-handbook

    • For more information: Respiratory diseases

      Useful websites

      Australian Centre for Airways disease Monitoring (ACAM) at http://www.asthmamonitoring.org

      National Asthma Council Australia at http://www.nationalasthma.org.au

      Australian Bureau of Statistics at http://www.abs.gov.au

      Australian Institute of Health and Welfare at http://www.aihw.gov.au

      healthdirect at http://www.healthdirect.gov.au

Last Updated At: Wednesday, 17 April 2019